Animal study · mice

NSI-189 reversed cognitive and motor deficits in Angelman mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds early mouse evidence that NSI-189 may be worth studying for Angelman syndrome, but it is not a human result.

Kind
Animal study
Studied in
Mice
Published
2019
Journal
Neuropharmacology

What they tested

The team tested whether NSI-189 could improve brain signaling and reverse cognitive and motor problems in a mouse model of Angelman syndrome.

How the study was done

A preclinical study in mice. Hippocampal slices from normal mice and Angelman syndrome model mice were treated with NSI-189 in the lab, and Angelman model mice and normal mice also got a short course of daily NSI-189 injections.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In hippocampal slices from normal mice, NSI-189 raised LTP (long-term potentiation, a lasting strengthening of signals between nerve cells), and the effect grew with dose and time. It also raised LTP in slices from Angelman model mice. In Angelman model mice, a short course of daily injections reversed impairments in cognitive and motor function, and normal mice performed slightly better. These effects went along with activation of the TrkB and Akt pathways.

What it doesn’t show

This was work in mice and mouse brain tissue, not people with Angelman syndrome. The treatment course was short, so it does not show longer-term effects or safety.

The paper

Liu et al. Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189. Neuropharmacology. 2019.

The compound

More studies on NSI-189

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo